The Federal Circuit affirmed the Trademark Trial and Appeal Board's dismissal of Fuente Marketing's opposition to a stick-figure design mark for vaporizers, holding that the dissimilarity of the marks alone was dispositive on the question of likelihood of confusion.
The Federal Circuit reversed summary judgment of noninfringement in VLSI's patent suit against Intel, reviving claims tied to multicore processor performance under both extraterritoriality and doctrine of equivalents theories.
The Federal Circuit reversed a $17.3M trade secret verdict and patent invalidity finding tied to a cosmetic medical implant, holding that information disclosed in publicly available patents is not protectable as a trade secret under California law.
The Federal Circuit reversed a district court ruling that had invalidated Teva's headache treatment patents under § 112, distinguishing the case from Amgen v. Sanofi by focusing on what the method-of-use claims actually cover.
